Early Brain Injury and Soluble ST2 After Nontraumatic Subarachnoid Hemorrhage

Stroke. 2021 Aug;52(8):e494-e496. doi: 10.1161/STROKEAHA.121.035372. Epub 2021 Jun 25.

Riana L Schleicher^{1

2}, Matthew B Bevers³, Daniel B Rubin¹, Matthew J Koch^{4

5}, Søren Bache^{6

7}, India A Lissak¹, Aman B Patel⁴, Eric S Rosenthal¹, Kirsten Møller^{6

7}, W Taylor Kimberly^{1

2}

¹ Division of Neurocritical Care (R.L.S., D.B.R., I.A.L., E.S.R., W.T.K.), Massachusetts General Hospital, Boston.
² Center for Genomic Medicine (R.L.S., W.T.K.), Massachusetts General Hospital, Boston.
³ Divisions of Stroke, Cerebrovascular and Critical Care Neurology, Brigham and Women's Hospital, Boston, MA (M.B.B.).
⁴ Department of Neurosurgery (M.J.K., A.B.P.), Massachusetts General Hospital, Boston.
⁵ Department of Neurosurgery, University of Illinois at Chicago (M.J.K.).
⁶ Department of Neuroanaesthesiology, Rigshospitalet (S.B., K.M.), University of Copenhagen, Denmark.
⁷ Department of Clinical Medicine, Faculty of Health and Medical Sciences (S.B., K.M.), University of Copenhagen, Denmark.

Abstract

[Figure: see text].

Keywords: biomarkers; brain injuries; risk factors; subarachnoid hemorrhage.